logo

Intellia Therapeutics, Inc. (NTLA)



Trade NTLA now with
  Date
  Headline
11/2/2018 6:30:36 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q2 19 Estimate To -0.54 From -0.56
11/2/2018 6:30:17 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q1 19 Estimate To -0.50 From -0.38
11/2/2018 6:29:59 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) FY18 Estimate To -1.89 From -2.00
11/2/2018 6:29:42 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) Q4 18 Estimate To -0.34 From -0.40
11/2/2018 6:23:22 AM Wedbush Cuts Intellia Therapeutics, Inc. (NTLA) To Neutral From Outperform With $20 Down from $36 Price Target
10/31/2018 7:41:05 AM Intellia Therapeutics Q3 Loss Per Share $0.53 Vs Loss $0.44 Prior Year
10/29/2018 4:41:16 PM Intellia Therapeutics Names Glenn Goddard EVP And CFO
10/18/2018 8:40:05 AM Intellia Therapeutics Presents New Data In In Vivo And Ex Vivo Programs At The 26th ESGCT
9/10/2018 7:02:53 AM F-star Appoints Nessan Bermingham As Chairman Of Board Of Directors
8/2/2018 10:08:57 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY18 Rev. Estimate To 38.6 M From 33.5 M
8/2/2018 10:08:35 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY18 Estimate To -2.00 From -2.12
8/2/2018 10:08:03 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q3 18 Estimate To -0.57 From -0.62
8/1/2018 7:48:23 AM Intellia Therapeutics Q2 Net Loss $22.2 Mln Or $0.52/Shr Vs Loss $15.6 Mln Or $0.45/Shr Last Year
6/19/2018 9:10:02 AM CRISPR, Intellia Therapeutics And Caribou Biosciences Announce Grant Of US Patent For CRISPR/Cas9 Genome Editing
5/18/2018 7:25:49 AM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $36 Price Target
5/17/2018 7:33:37 AM Intellia Therapeutics Announces WT1 As Its First Cell Therapy Target
5/14/2018 7:34:27 AM New Scientific Advisors Focused On Cell Therapy In Immuno-Oncology And Autoimmunity Join Intellia Therapeutics
5/3/2018 9:41:29 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY18 Rev. Estimate To 33.5 M From 31.0 M
5/3/2018 9:41:05 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) FY18 Estimate To -2.12 From -2.49
5/3/2018 9:40:47 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q4 18 Estimate To -0.40 From -0.48